April 27, 2020
The Honorable Doug Ducey
1700 West Washington St.
Phoenix, AZ 85007
Dear Governor Ducey:
This concerns your Executive Order forbidding prophylactic use of chloroquine (CQ) or hydroxychloroquine (HCQ) unless peer-reviewed evidence becomes available.
Attached and posted here () is a summary of peer-reviewed evidence, indexed in PubMed, concerning the use of CQ and HCQ against coronavirus. We believe that there is clear and convincing evidence of benefit both pre-exposure and post-exposure.
In addition, Michael J. A. Robb, M.D., of Phoenix is compiling all reports as they come in. As of this date, the total number of reported patients treated with HCQ, with or without azithromycin and zinc, is 2,333. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill.
Most of the data concerns use of HCQ for treatment, but one study included used the medication as prophylaxis with excellent results. Many nations, including Turkey and India, are protecting medical workers and contacts of infected persons prophylactically. According to worldometers.info, deaths per million persons from COVID-19 as of Apr 27 are 167 in the U.S., 33 in Turkey, and 0.6 in India.
Based on this evidence, we request that you rescind your Executive Orders impeding the use of CQ and HCQ and further order that administrative agencies not impose any requirements on the prescription of CQ, HCQ, azithromycin, or other drugs intended to treat or prevent coronavirus illness that do not apply equally to all approved medications that may be used off-label for any purpose.
Respectfully,
Michael J. A. Robb, M.D.
President, Arizona State Chapter of the Association of American Physicians and Surgeons
Jane M. Orient, M.D.
Executive Director, Association of American Physicians and Surgeons
CC Speaker Rusty Bowers, Rep. Warren Petersen, Rep. Nancy Barto, Sen. Karen Fann, Sen. Rick Gray, and Sen. Kate Brophy-McGee
Attachments:
Sequential CQ / HCQ Research Papers and Reports, January to April 20, 2020
The probabilities of clinical success using hydroxychloroquine, azithromycin and zinc against the novel betacoronavirus, COVID-19, revised Apr 26, 2020
